Clinical Trials on Lipids

Total 3888 results

Organon and Co

Withdrawn

A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) (VYCTORY)

Dyslipidemia
Kowa Company, Ltd.

Completed

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Sang Yeoup Lee

Completed

Ulmus Macrocarpa Hance Extract and Lipid Profile

Dyslipidemias

Korea, Republic of
Eli Lilly and Company

Completed

A Study of LY3475766 in Healthy Participants

Dyslipidemias

United States
Kowa Company, Ltd.

Completed

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Dyslipidemias

Japan
Federal University of Minas Gerais
Allergan Sales, LLC

Unknown

Study of White Adipose Tissue Remodeling by Cryolipolysis in Humans

Lipid Metabolism Disorders | Metabolic Disease

Brazil
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study (AT GOAL)

Dyslipidemias

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

Dyslipidemias

Belgium
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand

Dyslipidemias

Thailand
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol (LA ATGOAL)

Dyslipidemias

Brazil, Colombia, Panama, Mexico, Guatemala, Chile, Ecuador, Venezuela
University of Sorocaba

Completed

Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study

Dyslipidemias

Brazil
Yonsei University

Completed

Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia

Dyslipidemias

Korea, Republic of
Rigshospitalet, Denmark

Withdrawn

Vascular Inflammation and Cholesterol Lowering Therapy

Lipid Lowering, Vascular Inflammation

Denmark
Hoffmann-La Roche

Completed

A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Dyslipidemia

United States
Daewon Pharmaceutical Co., Ltd.

Unknown

Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

Dyslipidemias

Korea, Republic of
Kuhnil Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled

Dyslipidemias
National Research Council, Spain

Completed

Cardiometabolic Response to a Sodium-bicarbonated Mineral Water

Dyslipidemia
Ajinomoto Foods Europe SAS
Naturalpha; Institut Polytechnique LaSalle Beauvais

Completed

Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia (LLAX)

Dyslipidemias

France
Ludwig-Maximilians - University of Munich

Completed

The Metabolic Effect of Walnuts in Healthy Subjects (WALDI)

Lipid Metabolism Disorders

Germany
Novartis

Completed

Fluvastatin in Adults With Dislipidemia With History of Muscle Problems

Dyslipidemia

Germany, United States
University of Miami
Humana Inc.

Completed

Improving Adherence to Statins Among Minority Populations

Dyslipidemia

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)

Dyslipidemia
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

Dyslipidemia

Korea, Republic of
Pronova BioPharma

Terminated

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

Dyslipidemia

United States
Merck Sharp & Dohme LLC

Completed

MK0524A Bioequivalence Study (0524A-059)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

MK0524B Bioequivalence Study (0524B-070)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)

Dyslipidemia
Hospital de Clinicas de Porto Alegre

Completed

Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women

Dyslipidemia
Xention Ltd

Completed

TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) (TULIP)

Dyslipidemia

Denmark, Netherlands
University of California, San Diego
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels

Dyslipidemias

United States
China Academy of Chinese Medical Sciences

Completed

A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia

Dyslipidemia
New York Hospital Queens
NYHQ Cardiac Health Center; Pivotal Therapeutics

Unknown

An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels (CARE)

Dyslipidemia

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects

Dyslipidemia

Germany
Akros Pharma Inc.

Completed

Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
University of Nevada, Las Vegas

Completed

Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia

Dyslipidemia

United States
AstraZeneca

Withdrawn

Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes (DEMAND)

Dyslipidemia
AstraZeneca

Completed

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria (CEPHEUS)

Dyslipidemia

Bulgaria
AstraZeneca

Completed

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients (RACHEL)

Dyslipidemias
University of Washington
Upsher-Smith Laboratories

Completed

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Hellenic Atherosclerosis Society

Not yet recruiting

EPIRUS FH Reverse Cascade Screening

Familial Hypercholesterolemia
Odense University Hospital

Not yet recruiting

Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection. (FIND)

Familial Hypercholesterolemia

Denmark
Tang-Du Hospital
Air Force Military Medical University, China

Not yet recruiting

Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH (ENDFH)

Familial Hypercholesterolemia

China
Children's Hospital of Fudan University

Not yet recruiting

Child-Parent Familial Hypercholesterolemia Screening

Familial Hypercholesterolemia
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of MK-0616 (Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

Hypercholesterolemia | Familial Hypercholesterolemia

Colombia, Israel, Taiwan, United States, Argentina, China, Germany, Italy, Japan, Korea, Republic of, Mexico, South Africa, Spain, Turkey
Organon and Co

Completed

Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)

Familial Hypercholesterolemia
Northwestern University
University of Pennsylvania; Family Heart Foundation

Enrolling by invitation

Penn Family Screening for Familial Hypercholesterolemia (NHLBI-R33)

Familial Hypercholesterolemia

United States
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)

Cerebrotendinous Xanthomatoses

Jordan

3

Subscribe